Acceder Registro /

JOSE ANTONIO ROS LUCAS

Buscador

Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V. What pulmonologists think about the asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015. PubMed PMID: 26270415; PubMed Central PMCID: PMC4507793.
AÑO: 2015; IF: 2.772
Autores:
Tyrkalska SD, Pedoto A, Martinez-Lopez A, Ros-Lucas JA, Mesa-Del-Castillo P, Candel S, Mulero V. Silica crystals activate toll-like receptors and inflammasomes to promote local and systemic immune responses in zebrafish. Dev Comp Immunol. 2023 Jan;138:104523. doi: 10.1016/j.dci.2022.104523. Epub 2022 Aug 30. Erratum In: Dev Comp Immunol. 2022 Nov 23;:104591. PubMed PMID: 36055417.
AÑO: 2023; IF: 2.9
Autores:
Ros-Lucas JA, Pascual-Figal DA, Noguera-Velasco JA, Hernandez-Vicente A, Cebreiros-Lopez I, Arnaldos-Carrillo M, Martinez-Ardil IM, Garcia-Vazquez E, Aparicio-Vicente M, Solana-Martinez E, Ruiz-Martinez SY, Fernandez-Mula L, Andujar-Espinosa R, Fernandez-Suarez B, Sanchez-Caro MD, Penalver-Mellado C, Ruiz-Lopez FJ. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia. Sci Rep. 2022 Apr 25;12(1):6738. doi: 10.1038/s41598-022-10726-7. PubMed PMID: 35469047; PubMed Central PMCID: PMC9037059.
AÑO: 2022; IF: 4.6
Autores:
Arnaldos-Carrillo M, Noguera-Velasco JA, Martinez-Ardil IM, Riquelme-Perez A, Cebreiros-Lopez I, Hernandez-Vicente A, Ros-Lucas JA, Khan A, Bayes-Genis A, Pascual-Figal D. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19. Med Clin (Barc). 2023 Sep 8;161(5):185-191. doi: 10.1016/j.medcli.2023.04.005. Epub 2023 Apr 11. PubMed PMID: 37137804; PubMed Central PMCID: PMC10086099.
AÑO: 2023; IF: 3.9
Autores:

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R